Physician profile
William Cross
NPI 1124221502
$34,434.30
in general payments reported to CMS, 2019-2025
13 companies · $14K in 2025
The $14K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $1,875 · 2021: $449 · 2022: $6,657 · 2023: $3,953 · 2024: $7,141 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $16K · Consulting Fee: $4,750 · Food and Beverage: $3,319 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $15,688.15 |
| Consulting Fee | $4,750.00 |
| Food and Beverage | $3,319.19 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteocentric Technologies, INC. | $19,350.80 | 2021-2025 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Si-Bone, INC. | $6,460.11 | 2024-2025 | |
| Synthes Gmbh | $5,118.31 | 2020-2023 | |
| Cerapedics INC. | $1,892.22 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Stryker Corporation | $547.39 | 2019-2025 | Axsos, System 9 Cd Nxt, Ezout |
| Zimmer Biomet Holdings, INC. | $292.24 | 2019-2022 | |
| Alphatec Spine, INC | $216.34 | 2023 | |
| Globus Medical, INC. | $164.94 | 2024 | Excelsius Deformity |
| Medtronic, INC. | $153.30 | 2025 | Mazor X System |
| Bonalive INC | $116.52 | 2024-2025 | |
| Depuy Synthes Sales INC. | $79.53 | 2019-2022 | |
| Bone Support INC. | $27.85 | 2025 | Cerament G, Ceramentbone Void Filler |
| Biocomposites INC | $14.75 | 2025 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,049,986.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Cross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.